As the Russian interference probe drags on, a new report places Special Counsel Robert Mueller’s investments under a microscope. According to 2017 SEC Fillings, Mueller is invested in a hedge fund betting against Gazprom, the state-owned energy giant in Russia.

Offended America reports:

Mueller has been an investor in Mellon Optima L/S Strategy Fund, LLC for many years, according to his financial disclosures. That fund consists of holdings of other hedge funds in a structure commonly referred to as a “fund of funds”. According to 2017 SEC Filings , one of the funds held by the Mellon Optima L/S Strategy Fund is the OCCO Eastern European Fund, run by Charlemagne Capital. The fund released a performance overview on August 31st that said in part: “August was a relatively quiet month for markets and a strong one for the portfolio. The NAV gained 142 bps over the month. Russia was again the main driver with supportive contributions from other markets.”

Performance Review of the OCCO Eastern European Fund

TRENDING: FBI Agent Who Uncovered Weiner Laptop with Hillary's Emails says FBI Leadership Told Him to Erase All of His Findings

The OCCO Eastern European Fund also stated in late August 2017 that “Our single largest position at ten percent total gross exposure is the 5% long position in Novatek paired with a cash neutral short position in Gazprom.” This means that the fund is betting against Russia’s state-owned natural gas company, Gazprom, while going long Gazprom’s main competitor Novatek, which is the largest non-state owned natural gas company in Russia. According to Charlemagne Capital, the OCCO Eastern European Fund is based in the Cayman Islands and is has a net-long position in the Russian markets. This means that Robert Mueller gains financially if the Russian market does well.

While the dollar amount Mueller made was not disclosed, the report at hand is particularly noteworthy as evidence pointing to the Special Counsel’s role in the Clinton-Uranium One deal has come under investigation by House and Senate investigators.